1. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris; and Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, Paris, France (V.-T.T.)
2. Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria; and Center for Public Health Methods, RTI International, Research Triangle Park, North Carolina (G.G.)
3. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France (S.Y., F.A.)
4. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France; and Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, Paris, France (I.B.)
5. Institute for Evidence in Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany (L.S., J.S., J.M.)
6. Department for Evidence-based Medicine and Evaluation, University for Continuing Education Krems, Krems, Austria (I.S.)
7. Epidemiology in Dermatology and Evaluation of Therapeutics (EpiDermE)–EA 7379, University Paris Est Créteil Val de Marne, Créteil, France (S.A.)
8. Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAe, Centre for Research in Epidemiology and Statistics (CRESS), Paris, France; Centre d’Epidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, Paris, France; and Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York (P.R.).